BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8533551)

  • 21. [Anaphylactic reaction as a side-effect of administration of general anesthetics and neuromuscular blocking agents].
    Milavec D; Husedzinović I
    Lijec Vjesn; 2006; 128(9-10):317-21. PubMed ID: 17128671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Severe peranesthetic anaphylactic accidents].
    Laxenaire MC; Moneret-Vautrin DA; Vervloët D; Alazia M; François G
    Ann Fr Anesth Reanim; 1985; 4(1):30-46. PubMed ID: 2580464
    [No Abstract]   [Full Text] [Related]  

  • 23. Adverse effects of neuromuscular blockers and their antagonists.
    Naguib M; Magboul MM
    Drug Saf; 1998 Feb; 18(2):99-116. PubMed ID: 9512917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuromuscular transmission and its pharmacological blockade. Part 2: Pharmacology of neuromuscular blocking agents.
    Booij LH
    Pharm World Sci; 1997 Feb; 19(1):13-34. PubMed ID: 9089750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for mast cell tryptase and serum IgE antibodies in 18 patients with anaphylactic shock during general anaesthesia.
    Dybendal T; Guttormsen AB; Elsayed S; Askeland B; Harboe T; Florvaag E
    Acta Anaesthesiol Scand; 2003 Nov; 47(10):1211-8. PubMed ID: 14616317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaphylactoid reactions to neuromuscular blockers: major role of IgE antibodies and possible contribution of IgE-independent mechanisms.
    Assem ES
    Monogr Allergy; 1992; 30():24-53. PubMed ID: 1280766
    [No Abstract]   [Full Text] [Related]  

  • 27. Diagnostic and predictive test procedures in patients with life-threatening anaphylactic and anaphylactoid drug reactions.
    Assem ES
    Allergol Immunopathol (Madr); 1984; 12(1):61-70. PubMed ID: 6203389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?
    Spoerl D; Nigolian H; Czarnetzki C; Harr T
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France. Seventh epidemiologic survey (January 2001-December 2002)].
    Mertes PM; Laxenaire MC;
    Ann Fr Anesth Reanim; 2004 Dec; 23(12):1133-43. PubMed ID: 15589352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe drug reactions during anaesthesia.
    Bird AG
    Adverse Drug React Acute Poisoning Rev; 1987; 6(3):117-40. PubMed ID: 2447764
    [No Abstract]   [Full Text] [Related]  

  • 31. Activation of human mast cells and basophils by general anaesthetic drugs.
    Marone G; Stellato C
    Monogr Allergy; 1992; 30():54-73. PubMed ID: 1280767
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cutaneous reactions secondary to anaesthetic induction with mivacurium].
    Miloudi Y; El Harrar N; Bensaid A; Hussein MA
    Ann Fr Anesth Reanim; 2007; 26(7-8):717. PubMed ID: 17572045
    [No Abstract]   [Full Text] [Related]  

  • 33. [Substances responsible for peranesthetic anaphylactic shock. A third French multicenter study (1992-94)].
    Laxenaire MC
    Ann Fr Anesth Reanim; 1996; 15(8):1211-8. PubMed ID: 9636797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sugammadex and rocuronium-induced anaphylaxis.
    Takazawa T; Mitsuhata H; Mertes PM
    J Anesth; 2016 Apr; 30(2):290-7. PubMed ID: 26646837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anesthetics responsible for anaphylactic shock. A French multicenter study].
    Laxenaire MC; Moneret-Vautrin DA; Widmer S; Mouton C; Guéant JL; Bonnet MC; Bricard H; Facon A; Lesage F; Valfrey J
    Ann Fr Anesth Reanim; 1990; 9(6):501-6. PubMed ID: 1980580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anaphylactoid reactions to muscle relaxants].
    Kress HG
    Anaesthesiol Reanim; 1992; 17(4):175-83, 186-94. PubMed ID: 1445608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Severe anaphylaxis from rocuronium].
    Kubitz JC; Krause T; Dietz R; Friederich P; Goetz AE
    Anaesthesist; 2006 Nov; 55(11):1169-71. PubMed ID: 16924517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous sensitivity to atracurium and vecuronium in patients suffering anaphylactoid reactions to neuromuscular blockers.
    Galletly DC; Treuren BC
    Anaesth Intensive Care; 1985 Aug; 13(3):305-10. PubMed ID: 2864882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anaphylaxis to muscle relaxants: an audit of ten years of allergy testing at the Royal Adelaide Hospital.
    Brereton A; Russell WJ
    Anaesth Intensive Care; 2012 Sep; 40(5):861-6. PubMed ID: 22934871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: are there differences between males and females?
    Light KP; Lovell AT; Butt H; Fauvel NJ; Holdcroft A
    Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):151-60. PubMed ID: 16395661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.